STAT
JULY 28, 2024
As more than 7,500 clinicians and researchers converge in Philadelphia for the Alzheimer’s Association International Conference , a sharp division is emerging over new treatments for the disease that brings them together each year. This divide is over when to prescribe one of the newer drugs to treat Alzheimer’s disease. Lecanemab (Leqembi) was approved by the U.S.
pharmaphorum
JULY 28, 2024
The CHMP has backed LEO Pharma's delgocitinib for chronic hand eczema, considered to be one of its top pipeline prospects
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Patent Watch
JULY 28, 2024
Patient advocacy groups have become increasingly influential in the pharmaceutical industry, particularly in the development of generic drugs.
Express Pharma
JULY 28, 2024
The U.S. Food and Drug Administration recently warned patients and doctors about dosing errors associated with compounded versions of Novo Nordisk’s weight-loss and diabetes drugs. The health regulator said it had received reports of adverse events, some requiring hospitalisation, that may be related to overdoses due to patients incorrectly self-administering the compounded drug and healthcare providers miscalculating doses.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Drug Patent Watch
JULY 28, 2024
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum standards for intellectual property protection globally, including patents […] Source
Pharmaceutical Technology
JULY 28, 2024
SecureCHEK AI is a Category Award Winner in four areas in the 2024 Pharmaceutical Technology Excellence Awards
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
PharmaTech
JULY 28, 2024
As the number of highly potent oral solid dose (HPOSD) drugs in development and on the market increases, so are regulator’s expectations regarding their safe manufacture. In this white paper Pfizer CentreOne examines what developers and their manufacturing partners need to know about its unique regulatory challenges and how to navigate HPOSD’s complex manufacturing environment successfully.
Pharmacy Joe
JULY 28, 2024
In this episode, I’ll discuss the risk factors associated with the development of venous thromboembolism in ICU patients. Episode 943: Risk Factors Associated With the Development of Venous Thromboembolism in ICU Patients Subscribe on iTunes , Android , or Stitcher An review and systematic analysis published in Critical Care Medicine evaluated 39 observational cohort studies involving over 700,000 patients to identify what risk factors were associated with the development of VTE in critically il
Drug Patent Watch
JULY 28, 2024
This chart shows the pharmaceutical companies with the most powder dosed drugs. For a different perspective, see the most popular dosage types.
Med Ed 101
JULY 28, 2024
We will compare aripiprazole versus risperidone and why a clinician might recommend one versus another. These two agents are two of the most commonly used antipsychotics in practice. Antipsychotics are most often used for psychiatric disorders like schizophrenia and bipolar disorder. They can also be considered for other behavioral issues and in the case of […] The post Aripiprazole Versus Risperidone Comparison appeared first on Med Ed 101.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Patent Watch
JULY 28, 2024
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Express Pharma
JULY 28, 2024
Paratek Pharmaceuticals has announced positive topline efficacy and safety data from a global, Phase III post-marketing commitment study of its novel antibiotic, a next-generation tetracycline, Nuzyra (omadacycline). In a study of 670 adults with moderate to severe community-acquired bacterial pneumonia (CABP), Nuzyra was found to be generally safe and well-tolerated.
Drug Patent Watch
JULY 28, 2024
ALOXI (palonosetron hydrochloride) Helsinn hlthcare Patent: 7,947,725 Expiration: Jul 30, 2024 See More … For more information on how DrugPatentWatch […] Source
Expert insights. Personalized for you.
349 
Let's personalize your content